Defensive coping and subclinical vascular disease risk - Associations with autonomic exhaustion in Africans and Caucasians: The SABPA study

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 438-443

  de Kock, A ^a   Malan, L ^a   Hamer, M ^b   Malan, N T ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coping; Ethnicity; Norepinephrine metabolite; Subclinical vascular disease

Indexed keywords

3 METHOXY 4 HYDROXYPHENOLGLYCOL; DRUG METABOLITE; GLYCOSYLATED HEMOGLOBIN; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; ALCOHOL ABUSE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; CAUCASIAN; COHORT ANALYSIS; COPING BEHAVIOR; DEFENSIVE BEHAVIOR; DIABETES MELLITUS; EXHAUSTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; STRESS; SYMPATHETIC TONE; ULTRASOUND; VASCULAR DISEASE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; ASYMPTOMATIC DISEASES; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; BLOOD PRESSURE MONITORING, AMBULATORY; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; LEAST-SQUARES ANALYSIS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SALIVA; SOUTH AFRICA; STRESS, PSYCHOLOGICAL; VASCULAR DISEASES; YOUNG ADULT;

EID: 84869502026     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.08.038     Document Type: Article

References (35)

1. De Kock A., Malan L., Potgieter J.C., Steenekamp W., Van der Merwe M.T. Metabolic syndrome indicators and target organ damage in urban active coping African and Caucasian men: the SABPA study. Exp Clin Endocrinol Diabetes 2012, 120(05):282-287.
2. Malan L., Malan N.T., Du Plessis A., Wissing M.P., Potgieter J.C., Seedat Y.K. The cost of coping: a cardio-neuro-metabolic risk for black South Africans?. Cardiovasc J Afr 2010 Jul-Aug, 21(4):183-185.
3. Olff M., Brosschot J.F., Godaert G., et al. Modulatory effects of defense and coping on stress-induced changes in endocrine and immune parameters. Int J Behav Med 1995, 2(2):85-103.
4. Chong R.Y., Uhart M., McCaul M.E., Johnson E., Wand G.S. Whites have a more robust hypothalamic-pituitary-adrenal axis response to a psychological stressor than blacks. Psychoneuroendocrinology 2008, 33(2):246-254.
5. Malan L., Malan N.T., Wissing M.P., Seedat Y.K. Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol Psychol 2008, 79(3):323-328.
6. Stapelberg R. Psychometric characteristics of the COPE and SACS in a Setswana speaking South African group 1999, Potchefstroom. p. 280. Available from:. http://www.sciencedirect.com/science/coping%20mechanisms.htm.
7. Mitoma M., Yoshimura R., Sugita A., et al. Stress at work alters serum brain-derived neurotrophic factor (BDNF) and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of stress?. Progr Neuro Psychopharmacol Biol Psychiatry 2007, 32:679-685.
8. Goldstein D.S., Eisenhofer G., Kopin I.J. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 2003, 305(3):800-811.
9. Reuster T., Rilke O., Oehler I. High correlation between salivary MHPG and CSF MHPG. Psychopharmacology 2002, 162:415-418.
10. Brydon L., Walker C., Wawrzyniak A., et al. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 2009, 23(2):217-224.
11. Guilliams T.G., Edwards L. Chronic stress and the HPA-axis: clinical assessment and therapeutic considerations. Stand 2010, 9(2):1-12.
12. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53:865-871.
13. Hamer M., Malan L. Sympathetic nervous activity, depressive symptoms, and metabolic syndrome in black Africans: the SABPA study. Stress 2012, 15(5):562-568.
14. World Medical Association Declaration of Helsinki Ethical principles for medical research involving human subjects 2008, Available from:. http://www.wma.net/e/policy/b3.htm.
15. Earle T.L., Linden W., Weinberg J. Differential effects of harassment on cardiovascular and salivary cortisol stress reactivity and recovery in women and men. J Psychosom Res 1999, 46:125-141.
16. Meijer R., Stork S., Evans G.W., Grobbee D.E., Bots M.L. Striking increases in carotid artery wall thickness in healthy subjects. Cerebrovasc Dis 2010, 30(5):448-455.
17. Summary of the 2007 European society of hypertension (ESH) and European society of cardiology (ESC) guidelines for the management of arterial hypertension. Vasc Health Risk Manag 2007, 3(6):783-795.
18. Mosteller R.D. Simplified calculation of body-surface area. N Engl J Med 1987, 317:1098.
19. Futter J.E., Cleland J.G., Clark A.L. Body mass indices and outcomes in patients with chronic heart failure. Eur J Heart Fail 2011, 13(2):207-213.
20. Stein J.H., Korcarz C.E., Hurst R.T., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement. J Am Soc Echocardiogr 2008, 93-111.
21. Amirkhan J.H. A factor analytically derived measure of coping: the coping strategy indicator. J Pers Soc Psychol 1990, 59(5):1066-1074.
22. Amirkhan J.H. Criterion validity of a coping measure. J Pers Assess 1994, 62(2):242-261.
23. Updegraff J.A., Gable S.L., Taylor S.E. What makes experiences satisfying? The interaction of approach-avoidance motivations and emotions in well-being. J Pers Soc Psychol 2004, 86(3):496-504.
24. The Merck manual of diagnosis and therapy 2011, 3754. John Wiley & Sons, San Francisco. 19th ed. R.S. Porter (Ed.).
25. Jarvis M.J., Fidler J., Mindell J., et al. Assessing smoking status in children, adolescents and adults: cotinine cut points revisited. Addiction 2008, 103:1553-1561.
26. American Diabetes Association Standards of medical care in diabetes - 2011. Diabetes Care 2011, 34(1):11-61.
27. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120(16):1640-1645.
28. Prinsloo J., Malan L., de Ridder J.H., Potgieter J.C., Steyn H.S. Determining the waist circumference cut off which best predicts the metabolic syndrome components in urban Africans: the SABPA study. Exp Clin Endocrinol Diabetes 2011, 119(10):599-603.
29. Mischel N.A., Mueller P.J. (In)activity-dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity. J Appl Phys 2011, 111(6):1854-1862.
30. Bertoni A.G., Whitt-Glover M.C., Chung H., et al. The association between physical activity and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2009, 169(4):444-454.
31. Geffken D.F., Cushman M., Burke G.L., et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001, 153(3):242-250.
32. Obrist P.A. Cardiovascular psychophysiology: a perspective 1981, Plenum, London, p. 18-23.
33. Norris P.A., Fahrion S.L., Oikawa L.O. Autogenic feedback training in psychophysiological therapy and stress management. Principles and practice of stress management 2007, The Guilford Press, New York. 3rd ed. P.M. Lehrer, R.L. Woolfolk, W.E. Sime (Eds.).
34. Schatzberg A.F., Schildkraut J.J. Recent studies on norepinephrine systems in mood disorders. Psychopharmacology: the fourth generation of progress 1995, 911-920. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
35. Schillinger M., Exner M., Amighi J., et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future events of patients with advanced atherosclerosis. Circulation 2003 Oct, 108:2323-2328.